- Home
- CTMX vs ORMP Comparison
CTMX vs ORMP Comparison
Compare CTMX & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- ORMP
- Stock Information
- Founded
- CTMX 2008
- ORMP 2002
- Country
- CTMX United States
- ORMP United States
- Employees
- CTMX N/A
- ORMP N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- CTMX Health Care
- ORMP Health Care
- Exchange
- CTMX Nasdaq
- ORMP Nasdaq
- Market Cap
- CTMX 349.6M
- ORMP 90.2M
- IPO Year
- CTMX 2015
- ORMP N/A
- Fundamental
- Price
- CTMX $1.96
- ORMP $2.29
- Analyst Decision
- CTMX Strong Buy
- ORMP Hold
- Analyst Count
- CTMX 3
- ORMP 1
- Target Price
- CTMX $5.67
- ORMP N/A
- AVG Volume (30 Days)
- CTMX 2.4M
- ORMP 94.3K
- Earning Date
- CTMX 11-06-2025
- ORMP 11-06-2025
- Dividend Yield
- CTMX N/A
- ORMP N/A
- EPS Growth
- CTMX 263.20
- ORMP N/A
- EPS
- CTMX 0.49
- ORMP N/A
- Revenue
- CTMX $141,100,000.00
- ORMP $2,000,000.00
- Revenue This Year
- CTMX N/A
- ORMP N/A
- Revenue Next Year
- CTMX N/A
- ORMP N/A
- P/E Ratio
- CTMX $3.99
- ORMP N/A
- Revenue Growth
- CTMX 18.01
- ORMP N/A
- 52 Week Low
- CTMX $0.40
- ORMP $1.82
- 52 Week High
- CTMX $3.10
- ORMP $3.09
- Technical
- Relative Strength Index (RSI)
- CTMX 42.56
- ORMP 56.24
- Support Level
- CTMX $2.04
- ORMP $2.17
- Resistance Level
- CTMX $2.16
- ORMP $2.45
- Average True Range (ATR)
- CTMX 0.13
- ORMP 0.07
- MACD
- CTMX -0.01
- ORMP 0.01
- Stochastic Oscillator
- CTMX 15.00
- ORMP 52.94
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc a clinical-stage, oncology-focused biopharmaceutical company developing novel, masked, conditionally activated biologics designed to be localized to the tumor microenvironment. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.